BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1625209)

  • 1. Electrophysiologic actions of clofilium and lidocaine in ischemically injured canine epicardium.
    Patterson E; Scherlag BJ; Lazzara R
    J Pharmacol Exp Ther; 1992 Jul; 262(1):375-82. PubMed ID: 1625209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic actions of BRB-I-28 in ischemically injured canine myocardium.
    Patterson E; Scherlag BJ; Berlin KD; Lazzara R
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):637-46. PubMed ID: 7681911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class III electrophysiologic actions of imidazole-substituted diheterabicyclononanes in canine myocardium.
    Patterson E; Scherlag BJ; Sangiah S; Garrison GL; Couch KM; Berlin KD; Lazzara R
    J Pharmacol Exp Ther; 1997 Apr; 281(1):155-62. PubMed ID: 9103493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic and arrhythmogenic actions of methyl lidocaine during the recovery phase after canine myocardial infarction.
    Patterson E; Gibson JK; Lucchesi BR
    Pharmacology; 1988; 36(2):73-83. PubMed ID: 3353442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic actions of d,l-sotalol and GLG-V-13 in ischemically injured canine epicardium.
    Patterson E; Scherlag BJ; Lazzara R; Garrison GL; Berlin KD
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):304-13. PubMed ID: 17878760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo.
    Costard-Jäckle A; Franz MR
    J Pharmacol Exp Ther; 1989 Oct; 251(1):39-46. PubMed ID: 2795468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological actions of BRB-I-28 in canine myocardial tissues.
    Patterson E; Scherlag BJ; Berlin KD; Lazzara R
    J Pharmacol Exp Ther; 1991 Nov; 259(2):558-65. PubMed ID: 1941607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic and electrophysiologic actions of clofilium in experimental canine models.
    Kopia GA; Eller BT; Patterson E; Shea MJ; Lucchesi BR
    Eur J Pharmacol; 1985 Oct; 116(1-2):49-61. PubMed ID: 4054216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency-dependent effects of antiarrhythmic drugs on action potential duration and refractoriness of canine cardiac Purkinje fibers.
    Nattel S; Zeng FD
    J Pharmacol Exp Ther; 1984 Apr; 229(1):283-91. PubMed ID: 6707943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic and antifibrillatory actions of the beta adrenergic receptor antagonist, dl-sotalol.
    Patterson E; Lynch JJ; Lucchesi BR
    J Pharmacol Exp Ther; 1984 Aug; 230(2):519-26. PubMed ID: 6086892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facilitation of reentry by lidocaine in canine myocardial infarction.
    Fazekas T; Scherlag BJ; Mabo P; Patterson E; Lazzara R
    Acta Physiol Hung; 1994; 82(3):201-13. PubMed ID: 7717083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic effects of E-4031, a class III antiarrhythmic agent, on re-entrant ventricular arrhythmias in a canine 7-day-old myocardial infarction model.
    Katoh H; Ogawa S; Furuno I; Sato Y; Yoh S; Saeki K; Nakamura Y
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1077-82. PubMed ID: 2359016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the disposition of [14C]clofilium and its cardiac electrophysiological effect.
    Lindstrom TD; Murphy PJ; Smallwood JK; Wiest SA; Steinberg MI
    J Pharmacol Exp Ther; 1982 Jun; 221(3):584-9. PubMed ID: 7086672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of potassium currents in rat ventricle by clofilium and its tertiary homolog.
    Castle NA
    J Pharmacol Exp Ther; 1991 Apr; 257(1):342-50. PubMed ID: 2019997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid inward current in ischemically-injured subepicardial myocytes bordering myocardial infarction.
    Patterson E; Scherlag BJ; Lazzara R
    J Cardiovasc Electrophysiol; 1993 Feb; 4(1):9-22. PubMed ID: 8287240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow antegrade excitation and delayed retrograde activation through an "inexcitable zone": A basis for arrhythmia formation in infarcted myocardium ex vivo.
    Patterson E; Scherlag BJ
    J Cardiovasc Electrophysiol; 2017 Oct; 28(10):1213-1222. PubMed ID: 28570022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate-dependent effects of lidocaine on His-Purkinje conduction in the intact neonatal heart--characterization and amplification by N-acetylprocainamide.
    Dise TL; Stolfi A; Clarkson CW; Pickoff AS
    J Pharmacol Exp Ther; 1991 Nov; 259(2):535-42. PubMed ID: 1719192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of class I anti-arrhythmic drugs in infarcted tissue.
    Man RY; Bril A
    Clin Invest Med; 1991 Oct; 14(5):466-75. PubMed ID: 1742923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.
    Nattel S
    J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic, antiarrhythmic and cardiovascular actions of UM301, a quaternary ammonium compound.
    Gibson JK; Patterson E; Lucchesi BR
    J Pharmacol Exp Ther; 1986 Apr; 237(1):318-25. PubMed ID: 3754279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.